Keywords: Spain, Pharmaceutical market, Farmaindustria, Reference pricing,

Spanish pharmaceutical market evolution

Article | 24 November 2009

Data from the Spanish Ministry of Health and Consumer Affairs pertaining to the month of August of 2009 shows that growth in public pharmaceutical expenditure in Spain has reached 4.78%. This annual growth of expenditure is due to a 4.68% increase in the number of prescriptions, and a 0.09% on the average expenditure per prescription, reports the country’s trade body Farmaindustria.

The growth of the public pharmaceutical expenditure is still on its moderation path and, for the second consecutive month, remains below an annual 5%. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in